88 related articles for article (PubMed ID: 26518556)
21. Concurrent activation of MYC and BCL2 in B cell non-Hodgkin lymphoma cell lines by translocation of both oncogenes to the same immunoglobulin heavy chain locus.
Dyer MJ; Lillington DM; Bastard C; Tilly H; Lens D; Heward JM; Stranks G; Morilla R; Monrad S; Guglielmi P; Kluin-Nelemans JC; Hagemeijer A; Young BD; Catovsky D
Leukemia; 1996 Jul; 10(7):1198-208. PubMed ID: 8684002
[TBL] [Abstract][Full Text] [Related]
22. The chromatin remodeler Brg1 activates enhancer repertoires to establish B cell identity and modulate cell growth.
Bossen C; Murre CS; Chang AN; Mansson R; Rodewald HR; Murre C
Nat Immunol; 2015 Jul; 16(7):775-84. PubMed ID: 25985234
[TBL] [Abstract][Full Text] [Related]
23. Promiscuity of translocation partners in multiple myeloma.
Martin LD; Belch AR; Pilarski LM
J Cell Biochem; 2010 Apr; 109(6):1085-94. PubMed ID: 20127714
[TBL] [Abstract][Full Text] [Related]
24. Current perspectives in genetics of "double-hit" lymphoma with possible clinical implications.
Song YY; Tan YH; Yuan Y; Guo W; Pan ZY; Bai O
Cell Biochem Biophys; 2014 Jun; 69(2):203-8. PubMed ID: 24234731
[TBL] [Abstract][Full Text] [Related]
25. A p53 defect sensitizes various stages of B cell development to lymphomagenesis in mice carrying an IgH 3' regulatory region-driven c-myc transgene.
Fiancette R; Rouaud P; Vincent-Fabert C; Laffleur B; Magnone V; Cogné M; Denizot Y
J Immunol; 2011 Dec; 187(11):5772-82. PubMed ID: 22039300
[TBL] [Abstract][Full Text] [Related]
26. BCL2 and BCL3 are recurrent translocation partners of the IGH locus.
Szymanowska N; Klapper W; Gesk S; Küppers R; Martín-Subero JI; Siebert R
Cancer Genet Cytogenet; 2008 Oct; 186(2):110-4. PubMed ID: 18940474
[TBL] [Abstract][Full Text] [Related]
27. Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas.
Martín-Subero JI; Odero MD; Hernandez R; Cigudosa JC; Agirre X; Saez B; Sanz-García E; Ardanaz MT; Novo FJ; Gascoyne RD; Calasanz MJ; Siebert R
Genes Chromosomes Cancer; 2005 Aug; 43(4):414-23. PubMed ID: 15852472
[TBL] [Abstract][Full Text] [Related]
28. [Role of the Nucleolus in Rearrangements of the IGH Locus].
Iarovaia OV; Ioudinkova ES; Razin SV; Vassetzky YS
Mol Biol (Mosk); 2018; 52(2):210-219. PubMed ID: 29695689
[TBL] [Abstract][Full Text] [Related]
29. MYC rearranged B-cell neoplasms: Impact of genetics on classification.
Haberl S; Haferlach T; Stengel A; Jeromin S; Kern W; Haferlach C
Cancer Genet; 2016 Oct; 209(10):431-439. PubMed ID: 27810071
[TBL] [Abstract][Full Text] [Related]
30. Spatial proximity of translocation-prone gene loci in human lymphomas.
Roix JJ; McQueen PG; Munson PJ; Parada LA; Misteli T
Nat Genet; 2003 Jul; 34(3):287-91. PubMed ID: 12808455
[TBL] [Abstract][Full Text] [Related]
31. A second B cell-specific enhancer 3' of the immunoglobulin heavy-chain locus.
Pettersson S; Cook GP; Brüggemann M; Williams GT; Neuberger MS
Nature; 1990 Mar; 344(6262):165-8. PubMed ID: 2106628
[TBL] [Abstract][Full Text] [Related]
32. Altered subcellular localization of c-Myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation.
Ruzinova MB; Caron T; Rodig SJ
Am J Surg Pathol; 2010 Jun; 34(6):882-91. PubMed ID: 20442643
[TBL] [Abstract][Full Text] [Related]
33. Cytomorphologic findings of B-cell lymphomas with concurrent IGH/BCL2 and MYC rearrangements (dual-translocation lymphomas).
da Cunha Santos G; Ko HM; Saieg MA; Boerner SL; Lai SW; Bailey D; Geddie WR
Cancer Cytopathol; 2011 Aug; 119(4):254-62. PubMed ID: 21560251
[TBL] [Abstract][Full Text] [Related]
34. Rapid induction of B-cell lymphomas in mice carrying a human IgH/c-mycYAC.
Bützler C; Zou X; Popov AV; Brüggemann M
Oncogene; 1997 Mar; 14(11):1383-8. PubMed ID: 9178899
[TBL] [Abstract][Full Text] [Related]
35. Activator proteins which regulate immunoglobulin heavy chain gene transcription in B lymphocytes.
Roman C; Riggs K; Merrell K; Calame K
Prog Clin Biol Res; 1990; 352():241-8. PubMed ID: 2119507
[TBL] [Abstract][Full Text] [Related]
36. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
[TBL] [Abstract][Full Text] [Related]
37. Insertion of c-Myc into Igh induces B-cell and plasma-cell neoplasms in mice.
Park SS; Kim JS; Tessarollo L; Owens JD; Peng L; Han SS; Tae Chung S; Torrey TA; Cheung WC; Polakiewicz RD; McNeil N; Ried T; Mushinski JF; Morse HC; Janz S
Cancer Res; 2005 Feb; 65(4):1306-15. PubMed ID: 15735016
[TBL] [Abstract][Full Text] [Related]
38. Pre-B-cell leukemia with a t(8; 14) and a t(14; 18) translocation is preceded by follicular lymphoma.
Gauwerky CE; Hoxie J; Nowell PC; Croce CM
Oncogene; 1988 May; 2(5):431-5. PubMed ID: 3131717
[TBL] [Abstract][Full Text] [Related]
39. A rare case of IGH/MYC and IGH/BCL2 double hit primary plasma cell leukemia.
Kalff A; Khong T; Wall M; Gorniak M; Mithraprabhu S; Campbell LJ; Spencer A
Haematologica; 2015 Feb; 100(2):e60-2. PubMed ID: 25381133
[No Abstract] [Full Text] [Related]
40. Identification of IGHCδ-BACH2 fusion transcripts resulting from cryptic chromosomal rearrangements of 14q32 with 6q15 in aggressive B-cell lymphoma/leukemia.
Kobayashi S; Taki T; Chinen Y; Tsutsumi Y; Ohshiro M; Kobayashi T; Matsumoto Y; Kuroda J; Horiike S; Nishida K; Taniwaki M
Genes Chromosomes Cancer; 2011 Apr; 50(4):207-16. PubMed ID: 21319257
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
